Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
ORD
Connection
HTTP/2
Language
Not provided

Ray ID: a46c52a45b7ff824

Jump to content

// Workers AI · dad joke modeWhat did Dioxaphetyl butyrate say? "I'm bonded to you.

From Wikipedia, the free encyclopedia
(Redirected from Dioxaphetyl Butyrate)
Dioxaphetyl butyrate
Clinical data
Other namesAmidalgon, Spasmoxal
Routes of
administration
Oral, Other ROA Unknown
ATC code
  • none
Legal status
Legal status
Identifiers
  • Ethyl 4-morpholin-4-yl-2,2-di(phenyl)butanoate
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard100.006.731 Edit this at Wikidata
Chemical and physical data
FormulaC22H27NO3
Molar mass353.462 g·mol−1
3D model (JSmol)
  • CCOC(=O)C(CCN1CCOCC1)(c1ccccc1)c1ccccc1
  • InChI=1S/C22H27NO3/c1-2-26-21(24)22(19-9-5-3-6-10-19,20-11-7-4-8-12-20)13-14-23-15-17-25-18-16-23/h3-12H,2,13-18H2,1H3 X markN
  • Key:LQGIXNQCOXNCRP-UHFFFAOYSA-N X markN
 X markNcheckY (what is this?)  (verify)

Dioxaphetyl butyrate (INN; trade names Amidalgon, Spasmoxal) is an opioid analgesic which is a diphenylacetic acid derivative, related to other open-chain opioid drugs such as dextropropoxyphene, levacetylmethadol (LAAM), lefetamine and dimenoxadol.[2][3]

It produces similar effects to other opioids, including dependence, euphoria, analgesia, sedation, constipation, dizziness and nausea.[4]

[edit]

Dioxaphetyl butyrate is listed as an internationally controlled opioid under Schedule I of the 1961 Single Convention on Narcotic Drugs.[ref]

In Australia, the Office of Drug Control lists it as a narcotic requiring import and export licensing and permits.[5]

In the United States it is a Schedule I Narcotic controlled substance with an ACSCN of 9621 and a 2013 annual aggregate manufacturing quota of zero.[6]

Chemistry

[edit]

Dioxaphetyl butyrate has the molecular formula C22H27NO3 and a molecular weight of approximately 353.45 g/mol.[7] Its IUPAC name is ethyl 4-(morpholin-4-yl)-2,2-diphenylbutanoate. It is also listed under the names Amidalgon and Spasmoxal. [8]

References

[edit]
  1. ↑ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
  2. ↑ "Dioxaphetyl butyrate". PubChem. U.S. National Library of Medicine. Retrieved 2019-06-03.
  3. ↑ "Dioxaphetyl butyrate | C22H27NO3". ChemSpider. Retrieved 2019-06-03.
  4. ↑ "Dioxaphetyl butyrate". drugcentral.org. Retrieved 2019-06-03.
  5. ↑ "Dioxaphetyl butyrate". Office of Drug Control. Australian Government Department of Health, Disability and Ageing. Retrieved 26 August 2026.
  6. ↑ "Misuse of Drugs Act : Legislative history · Part I Class A · Section 1(a): Explicitly named Class A substances". isomerdesign.com. Retrieved 2019-06-03.
  7. ↑ "Dioxaphetyl Butyrate". Inxight Drugs. National Center for Advancing Translational Sciences. Retrieved 26 August 2026.
  8. ↑ "Dioxaphetyl butyrate". go.drugbank.com. Retrieved 2026-08-26.